People from across the U.S. have filed lawsuits over several models of Smith & Nephew’s hip-replacement implants. About 130 of those lawsuits have been combined in a major federal litigation and more lawsuits are expected to be added to it.
Did you or a loved one suffer complications after receiving a hip implant? You may be eligible for compensation.
People have reported higher-than-normal adverse events with several Smith & Nephew hip implant models. In 2017, the U.S. Judicial Panel on Multidistrict Litigation combined several lawsuits over Smith & Nephew’s Birmingham Hip Resurfacing (BHR) hip implants in a Maryland federal court.
Smith & Nephew issued a field-safety notice on its BHR implants in 2015, saying the devices posed a risk of dislocation, fractures and other complications that could require surgery to correct. In addition, the UK-based company recalled its R3 Acetabular Hip Systems in 2012 and its Modular SMF and Modular Redapt Revision in 2016, over issues serious enough to spark more potential lawsuits.
Lawsuits over Smith & Nephew’s BHR hip implants are in the very early stages. There have been no trials, verdicts or settlements in the BHR cases yet. Attorneys are still taking cases and considering options for people affected by Smith & Nephew’s Modular SMF and Modular Redapt Revision Femoral Hip following recalls of those devices in 2016.
The first 28 lawsuits over Smith & Nephew’s Birmingham Hip Resurfacing (BHR) hip implants were combined in a multidistrict litigation (MDL) in Maryland federal court in April 2017. As of March 2018, a total of 140 lawsuits had been included in the MDL.
MDLs allow consolidating several similar lawsuits to pool resources and reduce duplication. This allows lawsuits to move more quickly through the legal process.
Smith & Nephew hip implants named in lawsuits have been the subject of recalls or reports of serious complications such as loosening, fractures or the need for revision surgery. At least five models have been the subject of individual lawsuits since 2013.
People who have filed hip replacement lawsuits against Smith & Nephew claim the complications they suffered were due to the devices’ design.
The implants named in lawsuits are metal-on-metal hips. That means a metal ball fits into a metal socket to form the replacement joint. Wear caused by these two metal parts rubbing against one another releases microscopic amounts of metals that can lead to serious complications from damage to the body to implant failure.
People who have filed lawsuits over Smith & Nephew hips claim the company designed and marketed defective implants when they should have known about problems with their products.
While Smith & Nephew settled some of the individual lawsuits over the R3 Acetabular Hip System, other lawsuits remain in the early stages of a national litigation.
The MDL in Maryland involves lawsuits from across the U.S. and has the potential to include a large number of new lawsuits in the months to come.
In 2007, Smith & Nephew paid $28.9 million to the U.S. Department of Justice to resolve an alleged kickback scheme in which it paid doctors to use its products.
In 2014, Smith & Nephew settled another case with the federal government for $11.3 million. The “whistle-blower” lawsuit claimed the company had sold Malaysian-made implants to the U.S. government while claiming the devices were made in America.
There are currently no class action lawsuits over Smith & Nephew hip implants. Problems with medical devices are usually handled through individual lawsuits.
If enough people file lawsuits over similar problems, their attorneys will sometimes seek to have the cases combined into a multidistrict litigation (MDL). MDLs, like class actions, allow plaintiffs to combine their resources. They also have other benefits in medical device cases.
Please seek the advice of a medical professional before making health care decisions.
Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.
Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.(855) 396-3709